D. Scott Neal, Inc. Abb Vie Inc. Transaction History

D. Scott Neal, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$159.82 - $182.1 $3.61 Million - $4.11 Million	22,578 Added 39.28%	80,056 $14.6 Million
Q4 2023 Jan 17, 2024	SELL	$137.6 - $154.97 $150,672 - $169,692	-1,095 Reduced 1.87%	57,478 $8.91 Million
Q3 2023 Oct 11, 2023	SELL	$133.59 - $154.65 $237,656 - $275,122	-1,779 Reduced 2.95%	58,573 $8.73 Million
Q2 2023 Jul 17, 2023	BUY	$132.51 - $164.9 $364,004 - $452,980	2,747 Added 4.77%	60,352 $8.13 Million
Q1 2023 Apr 12, 2023	SELL	$144.61 - $166.54 $664,916 - $765,750	-4,598 Reduced 7.39%	57,605 $9.18 Million
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $107,743 - $129,212	-779 Reduced 1.24%	62,203 $0
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $3.63 Million - $4.17 Million	-27,073 Reduced 30.06%	62,982 $8.45 Million
Q2 2022 Jul 11, 2022	BUY	$137.62 - $174.96 $11.9 Million - $15.1 Million	86,219 Added 2247.63%	90,055 $13.8 Million
Q1 2022 May 04, 2022	BUY	$131.98 - $163.75 $130,396 - $161,785	988 Added 34.69%	3,836 $622,000
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $305,960 - $387,128	2,848 New	2,848 $386,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $112,382 - $124,933	-1,264 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $79,814 - $94,438	-889 Reduced 41.29%	1,264 $117,000
Q3 2017 Oct 18, 2017	BUY	$69.85 - $89.22 $150,387 - $192,090	2,153	2,153 $191,000

3,697

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of D. Scott Neal, Inc., based on Form 13F filings with the SEC.

Stay updated on D. Scott Neal, Inc. with notifications on news.